Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
Kress, H.G., Koch, E.D., Kosturski, H., Steup, A., Karcher, K., Dogan, C., Etropolski, M., Eerdekens, M.
Published in European journal of pain (01.10.2016)
Published in European journal of pain (01.10.2016)
Get full text
Journal Article
Methodological Issues in Conducting Pilot Trials in Chronic Pain as Randomized, Double-blind, Placebo-controlled Studies
Tominaga, Y, Koga, H, Uchida, N, Wanibe, M, Hirose, K, Matsumura, T, Okamoto, A, Richarz, U, Etropolski, M
Published in Drug research (01.07.2016)
Published in Drug research (01.07.2016)
Get more information
Journal Article
A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects
Oh, C, Rengelshausen, J, Mangold, B, Etropolski, M, Rauschkolb, C, Wang, S S, Upmalis, D, Häufel, T
Published in International journal of clinical pharmacology and therapeutics (01.10.2010)
Published in International journal of clinical pharmacology and therapeutics (01.10.2010)
Get more information
Journal Article
Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study
Vinik, A, Shapiro, D, Rauschkolb-Löffler, C, Lange, B, Karcher, K, Pennett, D, Etropolski, M
Published in The journal of pain (01.04.2012)
Published in The journal of pain (01.04.2012)
Get full text
Journal Article
Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain
Biondi, David M, Xiang, Jim, Etropolski, Mila, Moskovitz, Bruce
Published in Journal of opioid management (01.09.2015)
Published in Journal of opioid management (01.09.2015)
Get more information
Journal Article
Safety and tolerability of tapentadol extended release (ER) versus oxycodone controlled release (CR) in elderly patients with chronic low back or osteoarthritis pain
Biondi, D, Xiang, J, Lange, R, Etropolski, M, Vorsanger, G, Moskovit, B
Published in The journal of pain (01.04.2010)
Published in The journal of pain (01.04.2010)
Get full text
Journal Article
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial
Buynak, Robert, MD, Rappaport, Stephen A., MD, Rod, Kevin, MD, Arsenault, Pierre, MD, Heisig, Fabian, PhD, Rauschkolb, Christine, MD, PhD, Etropolski, Mila, MD
Published in Clinical therapeutics (01.11.2015)
Published in Clinical therapeutics (01.11.2015)
Get full text
Journal Article
333 SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN
Lange, R, Lange, B, Greene, A, Okamoto, A, Etropolski, M, Ashworth, J
Published in Osteoarthritis and cartilage (2010)
Published in Osteoarthritis and cartilage (2010)
Get full text
Journal Article
Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain
Buynak, R, Shapiro, D, Okamoto, A, Lange, C, Etropolski, M
Published in The journal of pain (01.04.2009)
Published in The journal of pain (01.04.2009)
Get full text
Journal Article
Tapentadol extended release (ER) versus oxycodone controlled release (CR) for management of chronic low back or osteoarthritis pain: influence of prior opioid experience on study discontinuations due to constipation, nausea, or vomiting
Biondi, D, Xiang, J, Vorsanger, G, Moskovitz, B, Ashworth, J, Etropolski, M
Published in The journal of pain (01.04.2010)
Published in The journal of pain (01.04.2010)
Get full text
Journal Article
Tapentadol extended release (ER) versus oxycodone controlled release (CR) for management of chronic low back or osteoarthritis pain: analyses of study discontinuations due to constipation, nausea, or vomiting
Biondi, D, Xiang, J, Lange, R, Etropolski, M, Vorsanger, G, Moskovitz, B
Published in The journal of pain (01.04.2010)
Published in The journal of pain (01.04.2010)
Get full text
Journal Article
Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency
Eichenbaum, Gary, Göhler, Karin, Etropolski, Mila, Steigerwald, Ilona, Pergolizzi, Joseph, Kim, Myoung, Vorsanger, Gary
Published in Journal of opioid management (01.05.2015)
Published in Journal of opioid management (01.05.2015)
Get more information
Journal Article
A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity
Etropolski, M, Rauschkolb-Löffler, C, Shapiro, D, Okamoto, A, Lange, C
Published in The journal of pain (01.04.2009)
Published in The journal of pain (01.04.2009)
Get full text
Journal Article
334 INCIDENCE AND SEVERITY OF GASTROINTESTINAL TREATMENT-EMERGENT ADVERSE EVENTS IN PATIENTS TREATED WITH TAPENTADOL EXTENDED RELEASE (ER) OR OXYCODONE CONTROLLED RELEASE (CR) FOR RELIEF OF CHRONIC OSTEOARTHRITIS KNEE PAIN
Kuperwasser, B, Häufel, T, Kelly, K, Etropolski, M, Laschewski, F, Okamoto, A, Steup, A, Van Hove, I, Rauschkolb, C
Published in Osteoarthritis and cartilage (2009)
Published in Osteoarthritis and cartilage (2009)
Get full text
Journal Article
337 EVALUATION OF LONG-TERM TREATMENT WITH TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN: RESULTS FROM PATIENT AND PHYSICIAN GLOBAL ASSESSMENTS AND THE EUROQOL 5 DIMENSION QUESTIONNAIRE
Kuperwasser, B, Lange, R, McCann, B, Greene, A, Etropolski, M, Lange, B, Gilbert, J, Okamoto, A, Steup, A, Rauschkolb, C
Published in Osteoarthritis and cartilage (2009)
Published in Osteoarthritis and cartilage (2009)
Get full text
Journal Article